| Popis: |
Before the era of pulmonary arterial hypertension (PAH)-specific therapies, clinicians treating patients with pulmonary hypertension (PH) employed nonspecific, time-honored treatments in an effort to help these unfortunate patients. While the role of these therapies has not been rigorously studied they are still commonly used as adjuncts to PAH-specific therapies. This chapter outlines the logic and rationale behind the use of digoxin therapy, anticoagulation, oxygen therapy, diuretic therapy, and high-dose calcium channel blocker therapy and reviews the limited data supporting the use of these therapies in patients with PAH. |
